Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gene therapy -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (167)	9/29/1999 3:49:00 PM
From: Mike McFarland	Read Replies (3) \| Respond to of 319

A sad article Arizona teen undergoing experimental gene therapy dies seattletimes.com I put an IMHO over on the Yahoo Ariad thread, if any body has any points about the logic of owning ARIA for ARGENT rather than AVGN, TGEN or any of the others for exposure to the first wave of vectors, speak up. messages.yahoo.com A little perspective might be in order as well--how many people typically die during other experimental trials--do people very often die in early MAb trials? I would guess that it happens, but newbie hre is asking for you fellas' perspective.